STOCKHOLM, May 14, 2021 /PRNewswire/ -- On May 18th, 2021, Calliditas
Therapeutics AB (publ) ("Calliditas") will publish its financial
report for the first quarter of 2021, and at 2.30 pm CET will host a conference call to
present and discuss the results.
The event will be hosted by the company's CEO Renée
Aguiar-Lucander and CFO Fredrik
Johansson, and will be held in English. The presentation
will be webcast live and will also be made available online on the
Calliditas website after the call.
Webcast link:
https://tv.streamfabriken.com/calliditas-therapeutics-q1-2021
Teleconference: SE: +46850558366 UK: + 443333009271 US: +
18335268381
For further information, please contact:
Marie Galay, IR Manager,
Calliditas
Tel.: +44 79 55 12 98 45, email: marie.galay@calliditas.com
The information was sent for publication, through the agency
of the contact person set out above, on May 14, 2021 at 2:00 p.m.
CET.
About Calliditas
Calliditas Therapeutics is a biopharma company based in
Stockholm, Sweden focused on
identifying, developing and commercializing novel treatments in
orphan indications, with an initial focus on renal and hepatic
diseases with significant unmet medical needs. Calliditas' lead
product candidate, Nefecon, is a proprietary, novel oral
formulation of budesonide, an established, highly potent local
immunosuppressant, for the treatment of the autoimmune renal
disease IgA nephropathy, or IgAN, for which there is a high unmet
medical need and there are no approved treatments. Calliditas
successfully reported top line data of its global Phase 3 study in
IgAN in November of 2020 and, if approved, aims to commercialize
Nefecon in the United States on
its own and partner elsewhere. Calliditas is listed on Nasdaq
Stockholm (ticker: CALTX) and the Nasdaq Global Select Market
(ticker: CALT). Visit www.calliditas.com for further
information.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/calliditas-therapeutics/r/calliditas-therapeutics-to-host-conference-call-to-provide-business-update-for-the-first-quarter-of-,c3346790
The following files are available for download:
https://mb.cision.com/Main/16574/3346790/1417298.pdf
|
Q1 Inv Call
ENG
|
View original
content:http://www.prnewswire.com/news-releases/calliditas-therapeutics-to-host-conference-call-to-provide-business-update-for-the-first-quarter-of-2021-301291671.html
SOURCE Calliditas Therapeutics